WO2025220043 - SOLID STATE FORMS OF ACORAMIDIS AND PROCESS FOR THEIR PREPARATION

National phase entry is expected:
Publication Number WO/2025/220043
Publication Date 23.10.2025
International Application No. PCT/IN2025/050619
International Filing Date 18.04.2025
Title **
[English] SOLID STATE FORMS OF ACORAMIDIS AND PROCESS FOR THEIR PREPARATION
[French] FORMES À L'ÉTAT SOLIDE D'ACORAMIDIS ET LEUR PROCÉDÉ DE PRÉPARATION
Applicants **
DR. REDDY'S LABORATORIES LIMITED
Inventors
BUDHDEV, Rajeev Rehani
MADHRA, Mukesh Kumar
DWARAMPUDI, Adi Reddy
RAO B MADA, Mallikharjuna
MUTYAM, Latchi Reddy
THATIPAMULA, Sudhakar
KANDULA, Narendar
CHINTADA, Krishnarao
SIRAZODDIN, Md
PAL, Sharmistha
Priority Data
202441031173   18.04.2024   IN
202441094761   02.12.2024   IN
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting2013
EPO Filing, Examination, Granting11551
Japan Filing, Examination, Granting1968
South Korea Filing, Examination, Granting1768
USA Filing, Examination, Granting5940
MasterCard Visa
Total: 23,240
Contact Us
Abstract[English] The invention of the present application relates to novel synthetic methods of Acoramidis, its intermediate compounds, its pharmaceutically acceptable salts, solid state forms and pharmaceutical compositions thereof.[French] La présente invention concerne de nouveaux procédés de synthèse d'acoramidis, de ses composés intermédiaires, de ses sels pharmaceutiquement acceptables, de formes à l'état solide et de compositions pharmaceutiques de ceux-ci.